###begin article-title 0
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4</italic>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA</italic>
Interleukin-4 (IL4) and Interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control study
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 98 104 98 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 312 320 <span type="species:ncbi:9606">patients</span>
IL4/IL4RA pathway plays an important role in atopy and asthma. Different polymorphisms in IL4 and IL4RA genes have been described. Particularly, -33C>TIL4 and 576Q>RIL4RA SNPs have been independently associated to atopy and asthma. The purpose of this study was to analyse these polymorphisms in a population of patients with a well-characterized asthma phenotype.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 491 495 491 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 535 541 535 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 664 665 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 52 60 <span type="species:ncbi:9606">patients</span>
A total of 212 unrelated Caucasian individuals, 133 patients with asthma and 79 healthy subjects without symptoms or history of asthma or atopy and with negative skin prick tests were recruited. Lung function was measured by spirometry and asthma was specialist physician-diagnosed according to the ATS (American Thoracic Society) criteria and classified following the GINA (Global Initiative for Asthma) guidelines. Skin prick tests were performed according to EAACI recommendations. -33C>TIL4 was studied with TaqMan assay and 576Q>RIL4RA by PCR-RFLP technique. Hardy-Weinberg equilibrium was analysed in all groups. Dichotomous variables were analysed using chi2, Fisher exact test, Monte Carlo simulation test and odds ratio test. To model the effects of multiple covariates logistic regression was used.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 571 575 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 601 607 601 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 761 763 761 763 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 62 70 <span type="species:ncbi:9606">patients</span>
###xml 275 283 <span type="species:ncbi:9606">patients</span>
###xml 526 534 <span type="species:ncbi:9606">patients</span>
No statistically significant differences between the group of patients with asthma and the controls were found when the allele and genotype distribution of -33C>TIL4 and 576Q>RIL4RA polymorphisms were compared. However, the T allele of the -33C>TIL4 SNP was more frequent in patients with persistent asthma. Multivariate analysis adjusted for age and sex confirmed that carriers of allele T had an increased risk of persistent asthma (OR:2.77, 95%CI:1.18-6.49; p = 0.019). Analysis of combination of polymorphisms showed that patients carrying both the T allele of -33C>TIL4 and the A allele of 576Q>RIL4RA had an increased risk of asthma. This association was particularly observed in persistent asthma [Fisher's p value = 0.0021, Monte Carlo p value (after 104 simulations) = 0.0016, OR:3.39; 95% CI:1.50-7.66].
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 97 101 97 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 127 133 127 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 199 207 <span type="species:ncbi:9606">patients</span>
Our results show a trend of association between the genetic combination of the T allele of -33C>TIL4 and the A allele of 576Q>RIL4RA with asthma. This genetic variant was more frequently observed in patients with persistent asthma. As long as this study was performed in a small population, further studies in other populations are needed to confirm these results.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 350 354 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 580 584 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 627 628 627 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 690 691 690 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 822 824 822 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 961 963 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 964 966 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1046 1048 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1055 1061 1035 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 1106 1108 1086 1088 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1177 1179 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1180 1182 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1281 1287 1261 1267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 1344 1346 1324 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1347 1349 1327 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1704 1706 1680 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1771 1773 1747 1749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1907 1909 1883 1885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1910 1912 1886 1888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1913 1915 1889 1891 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 2113 2117 2089 2093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 2153 2159 2129 2135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 1614 1622 <span type="species:ncbi:9606">patients</span>
###xml 2191 2199 <span type="species:ncbi:9606">patients</span>
IL-4 is a Th2 cytokine that plays an essential role in IgE regulation. It triggers isotype switching from IgM to IgE, induces differentiation to Th2 phenotype on T cells and plays a critical role in the induction and maintenance of allergy.IL4 gene has been mapped to chromosome 5q31 where asthma and atopy have also been linked [1-3]. Evidence that IL4 polymorphisms are associated with total IgE levels and potentially with asthma and other allergy related phenotypes has been provided, although ethnical differences have been reported [4]. Specifically, the promoter region of IL4 has been associated with asthma phenotype [5] and a -33C>T polymorphism has been reported in this region [6]. An association between this polymorphism and asthma or atopy has been found, although this relation is still controversial [4,7-10]. IL-4 acts through the IL-4 receptor (IL-4R) that consists of two subunits, the alpha chain (IL-4Ralpha) and the gamma chain (gammac) [11,12]. IL-4Ralpha is a component of both the IL-4 and the IL-13 receptor complexes [13]. The IL4RA gene is located on chromosome 16p (16p12.1) [14], a region reported in linkage with atopy in different populations [15,16]. Several single-nucleotide polymorphisms (SNPs) have been identified in the coding region of the IL4RA gene, many of them resulting in aminoacid substitutions [17,18]. One of these polymorphisms, 576Q>R, consists of an A-to-G transition at nucleotide 1902, causing a change from glutamine to arginine at codon 576 (Q576R) in the cytoplasmic domain of the IL-4Ralpha. It has been reported that B-lymphocytes isolated from allergic patients bearing the 576Q>R mutation have an enhanced CD23 induction in response to IL-4 [19]. However, this result has not been confirmed by other authors [20]. Association of the 576Q>R polymorphism with the atopic phenotype has been described, but this relationship is still controversial [19,21-31]. Due to the central role of the IL-4/IL-4RA pathway in atopy and the scarce information about combinations of both genes in South European populations, we have analysed the -33C>T polymorphism of IL4 gene and the 576Q>R polymorphism of IL4RA gene in a Spanish population of patients with a well-characterized phenotype of asthma.
###end p 11
###begin title 12
Methods
###end title 12
###begin title 13
Subjects
###end title 13
###begin p 14
###xml 52 60 <span type="species:ncbi:9606">patients</span>
###xml 339 346 <span type="species:ncbi:9606">patient</span>
###xml 717 725 <span type="species:ncbi:9606">patients</span>
###xml 1309 1317 <span type="species:ncbi:9606">patients</span>
We studied 212 unrelated Caucasian individuals, 133 patients and 79 controls, recruited from the outpatient Allergy Department of the University Hospital of Salamanca. The study was performed following the recommendations of the Ethical Committee of the University Hospital of Salamanca and informed written consent was obtained from each patient. Individuals who met all the following criteria were selected as controls: (i) no symptoms or history of asthma or other pulmonary diseases; (ii) no symptoms or history of atopy; (iii) negative skin prick tests to a battery of common aeroallergens (<1 mm wheal greater than saline) and (iv) absence of first-degree relatives with a history of asthma or atopy. Asthmatic patients were recruited if they had specialist physician-diagnosed asthma with the following characteristics: (i) at least two symptoms consistent with asthma (cough, wheeze and dyspnoea); (ii) either a positive bronchial hyperresponsiveness or a positive bronchodilator test defined as a >/= 15% increase in baseline FEV1 after bronchodilator use; (iii) absence of other pulmonary disorders. Lung function was measured by spirometry according to ATS (American Thoracic Society) standards and severity of asthma was classified following GINA (Global Initiative for Asthma) guidelines. Asthma patients were grouped into intermittent and persistent by the clinical severity and into allergic and non allergic asthma by the clinical etiology.
###end p 14
###begin p 15
###xml 120 199 120 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D pteronisynuss, D farinae, L destructor, T putrescentiae, A siro, G domesticus</italic>
###xml 201 209 201 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E maynei</italic>
###xml 241 346 241 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P judaica, C album, A vulgaris, P lanceolata, O europaea, A alternata, C herbarum, P notatum, A fumigatus</italic>
###xml 934 937 934 935 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 348 351 <span type="species:ncbi:9615">dog</span>
###xml 353 356 <span type="species:ncbi:9685">cat</span>
###xml 367 372 <span type="species:ncbi:9796">horse</span>
###xml 377 383 <span type="species:ncbi:9986">rabbit</span>
###xml 771 779 <span type="species:ncbi:9606">Patients</span>
Skin prick tests were performed according to EAACI recommendations with a battery of common aeroallergens that included D pteronisynuss, D farinae, L destructor, T putrescentiae, A siro, G domesticus, E maynei, mix of grasses, mix of trees, P judaica, C album, A vulgaris, P lanceolata, O europaea, A alternata, C herbarum, P notatum, A fumigatus, dog, cat, hamster, horse and rabbit dander and cockroach (ALK-Abello, Madrid, Spain). Saline was used as negative control and histamine 10 mg/ml was used as positive control. Antihistamines were discontinued before skin testing according to published guidelines. Skin tests were considerer positive if at least one allergen elicited a wheal reaction of more than 3 mm of diameter after subtraction of the negative control. Patients were considered atopic if at least they had one positive skin test result. Total serum IgE was measured by a fluoroenzymeimmunoassay (Pharmacia Cap System(R); Pharmacia, Uppsala, Sweden), according to the manufacturer's instructions.
###end p 15
###begin title 16
Genotyping analysis
###end title 16
###begin p 17
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 495 501 495 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 711 713 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1659 1667 <span type="species:ncbi:9606">patients</span>
After purification from peripheral blood leukocytes, DNA was amplified by polymerase chain reaction (PCR). Genotyping of -33C>TIL4 SNP was performed using a TaqMan assay in the ABI 7700 sequence detector and the allelic discrimination software Sequence Detector v1.7 according to the manufacturer's recommendations (Applied Biosystems). Primers and probes were obtained by means of the Assays-by-Demand SNP genotyping service of Applied Biosystems, Assay ID: C 16176215. Genotyping of the 576Q>RIL4RA polymorphism was performed according to a previously published assay [28]. Two oligonucleotides were used to amplify the polymorphic region of IL4RA: 5'-CCCCCACCACCAGTGGCTACC-3' and 5'-CCAGGAATGAGGTCTTGGAA-3' [24]. PCR reactions were carried out in a total volume of 25 muL, containing 50 ng of DNA and 12.5 muL of PCR Master Mix 2 x (Promega, Madison, Wisconsin). Amplification was performed with an initial denaturation step at 94degreesC for 5 min followed by 30 cycles of denaturation at 94degreesC for 1 min, primer annealing at 55degreesC for 1 min, and extension at 72degrees for 1 min. A final extension was carried out at 72degrees for 10 min. A blank amplification tube was always run to check for the presence of contamination. Strict rules were taken to avoid contamination. PCR reactions were prepared on a laminar flow hood and PCR products were examined in a different room. PCR products were digested for 4 h at 37degreesC with 1 U of MspI (New England Biolab, Boston, Massachusetts) restriction enzyme. After enzymatic digestion of the amplified fragments, the samples were analyzed by electrophoresis in 3% nusieve agarose gel. Control and patients were not genotyped in separated batched and the analysis was performed blindly with respect to case-control status.
###end p 17
###begin title 18
Statistical analysis
###end title 18
###begin p 19
###xml 206 208 204 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 267 268 263 264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 326 328 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 395 398 391 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink">10 </sub>
###xml 1077 1079 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 65 73 <span type="species:ncbi:9606">patients</span>
For case-control studies, the allele and genotype frequencies in patients with asthma were compared to a control non-asthmatic population. All the groups were tested for Hardy-Weinberg equilibrium using chi2 analyses. The dichotomous variables were analysed using chi2, Fisher exact test, Monte Carlo simulation test (after 104 iterations) and odds ratio test. IgE levels were transformed to log10 values to produce a normal distribution for statistical analysis and analysed by ANOVA. To model the effects of multiple covariates on the dichotomous and continuous variables, logistic regression was used. In multivariate analysis, sex and age were included as potential covariates. A p-value less than 0.05 was considered statistically significant. Bonferroni correction was applied when appropriate. Case-control studies were also undertaken using combination of polymorphisms. Frequencies of combinations were estimated individually in controls and in samples to give the results of both single combinations and global data. For management of data, SHEsis software platform [32] and SPSS version 11 (SPSS Inc, Chicago, IL, USA) were used.
###end p 19
###begin title 20
Results
###end title 20
###begin title 21
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
-33C>TIL4 SNP
###end title 21
###begin p 22
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 481 483 481 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 612 616 612 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 172 180 <span type="species:ncbi:9606">patients</span>
###xml 267 275 <span type="species:ncbi:9606">patients</span>
###xml 372 380 <span type="species:ncbi:9606">patients</span>
Characteristics of patients and controls are shown in Table 1. Genotype and allele frequencies are shown in Table 2. The -33TIL4 allele was found at a frequency of 0.15 in patients with asthma versus 0.09 in controls. No statistically significant differences between patients with asthma and controls were found. However, we observed an increase of the -33T IL4 allele in patients with persistent asthma compared to controls [Fisher's p value = 0.014, Monte Carlo p value (after 104 simulations) = 0.019]. Multivariate analysis of the genotypes adjusted for age and sex confirmed a trend of association of -33C>TIL4 polymorphism with an increased risk of persistent asthma (OR: 2.77, 95% CI: 1.18-6.49; p = 0.019). No differences were found in the group of subjects suffering allergic asthma compared to controls. Analysis of the total IgE levels failed to reveal any significant difference (p = 0.22), even when separate analysis for each gender was performed (data not shown).
###end p 22
###begin p 23
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Demographic characteristics of patients
###end p 23
###begin p 24
SD: standard deviation
###end p 24
###begin p 25
y: years
###end p 25
###begin p 26
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 55 61 55 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
Genotype and allele frequencies of -33C>TIL4 and 576Q>RIL4RA SNPs
###end p 26
###begin p 27
HWE: Hardy-Weinberg Equilibrium
###end p 27
###begin p 28
###xml 57 59 57 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
* Fisher's p value = 0.013, Monte Carlo p value (after 104 simulations) = 0.019
###end p 28
###begin p 29
###xml 61 63 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
daggerFisher's p value = 0.023, Monte Carlo p value (after 104 simulations) = 0.037
###end p 29
###begin title 30
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
576Q>RIL4RA SNP
###end title 30
###begin p 31
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 307 308 307 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 317 323 317 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 66 74 <span type="species:ncbi:9606">patients</span>
###xml 169 177 <span type="species:ncbi:9606">patients</span>
576RIL4RA arginine allele (G) was found at a frequency of 0.16 in patients with asthma versus 0.21 in healthy subjects (Table 2). We did not observe differences between patients and controls in allele or genotype frequencies. No association was detected with asthma phenotype or with asthma severity (Table 2). 576Q>RIL4RA polymorphism was not related to total serum IgE levels in our population (p = 0.35).
###end p 31
###begin title 32
Gene-gene interaction analysis
###end title 32
###begin p 33
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 78 84 78 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 296 302 296 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 390 392 390 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 215 223 <span type="species:ncbi:9606">patients</span>
We did not detect differences in the global distribution of -33C>TIL4 / 576Q>RIL4RA combinations between the group of patients with asthma and the group of controls (Monte Carlo p value = 0.074) (Table 3). However, patients who were carriers of both the T allele of -33C>TIL4 and the A allele of IL4RA had an increased risk of asthma [Fisher's p value = 0.017, Monte Carlo p value (after 104 simulations = 0.012, odds ratio, 2.58; 95 % CI, 1.18-5.66].
###end p 33
###begin p 34
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 52 58 52 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
Distribution of combinations of -33C>TIL4 and 576Q>RIL4RA SNPs
###end p 34
###begin p 35
CTR, Controls; AA, Allergic Asthma; PA, Persistent Asthma
###end p 35
###begin p 36
* Odds ratio: 2.59 95% CI: 1.18-5.66
###end p 36
###begin p 37
** Odds ratio: 2.65 95% CI: 1.19-5.87
###end p 37
###begin p 38
*** Odds ratio: 2.62 95% CI: 1.17-5.90
###end p 38
###begin p 39
###xml 102 104 97 99 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
daggerGlobal distribution of genetic variants: Fisher's p value = 0.018, Monte Carlo p value (after 104 simulations) = 0.017
###end p 39
###begin p 40
double dagger Odds ratio: 3.39 95% CI: 1.50-7.66
###end p 40
###begin p 41
###xml 202 204 202 204 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 308 314 308 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 401 403 401 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
###xml 227 235 <span type="species:ncbi:9606">Patients</span>
Slight differences in the global distribution of genetic variants were detected between the group of patients with atopy and the group of controls [Fisher's p value = 0.05, Monte Carlo p value (after 104 simulations) = 0.045]. Patients who were carriers of both the T allele of -33C>TIL4 and the A allele of IL4RA had an increased risk of atopy [Fisher's p value = 0.013, Monte Carlo p value (after 104 simulations = 0.016, odds ratio, 2.64; 95 % CI, 1.93-5.87] (Table 3).
###end p 41
###begin p 42
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 80 88 <span type="species:ncbi:9606">patients</span>
Differences in genetic variants distribution were also observed in the group of patients with allergic asthma compared to controls, although these differences did not reach statistical signification globally considered (Fisher p value = 0.053, Monte Carlo p value = 0.053). Again the combination of T and A alleles showed a trend of association [Fisher's p value = 0.016, Monte Carlo p value = 0.017, odds ratio, 2.62; 95 % CI, 1.17-5.90] (Table 3).
###end p 42
###begin p 43
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 268 274 268 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 420 421 420 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 17 25 <span type="species:ncbi:9606">patients</span>
###xml 196 204 <span type="species:ncbi:9606">Patients</span>
When we compared patients with persistent asthma to controls, significant differences in the global combination distribution were observed (Fisher's p value = 0.018, Monte Carlo p value = 0.017). Patients who carried both the T allele of -33C>TIL4 and the A allele of IL4RA had an increased risk of persistent asthma [Fisher's p value = 0.0021, Monte Carlo p value = 0.0016, odds ratio, 3.39; 95 % CI, 1.50-7.66] (Table 3).
###end p 43
###begin title 44
Discussion
###end title 44
###begin title 45
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
-33C>TIL4 SNP
###end title 45
###begin p 46
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 31 37 31 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 551 552 551 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 180 188 <span type="species:ncbi:9606">patients</span>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
###xml 523 531 <span type="species:ncbi:9606">patients</span>
We studied -33C>TIL4 and 576Q>RIL4RA polymorphisms in a well-characterized Spanish population of patients with asthma and in a healthy control population. Controls were older than patients allowing a longer period for asthma diagnosis to be made. When we analysed the -33C>T polymorphism independently, we did not detect significant differences in allele or genotype frequencies between the group of patients and the group of controls. Nevertheless, we observed a higher incidence of the T allele of -33IL4 in the group of patients with asthma (Table 2).
###end p 46
###begin p 47
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 140 141 140 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 355 356 355 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 537 538 537 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 466 474 <span type="species:ncbi:9606">children</span>
An association between -33C>TIL4 polymorphism and asthma or atopy has been previously reported, although this association is controversial [4,7-9]. In previous studies, no statistically significant association between -33C>TIL4 polymorphism and atopic dermatitis, bronchial hyperresponsiveness, atopic rhinitis and skin prick test reactivity was found [7,9]. However, a significant trend for an association between serum IgE levels and this SNP has been detected in children with positive skin prick tests, independent of asthma status [7].
###end p 47
###begin p 48
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 77 85 <span type="species:ncbi:9606">patients</span>
As shown in table 2, we detected that the allele -33TIL4 is more frequent in patients with allergic asthma, although, we did not detect an association between this polymorphism and IgE levels.
###end p 48
###begin p 49
###xml 126 127 126 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 292 294 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
It has been reported that polymorphisms within the promoter region of IL4 gene seems to correlate with enhanced IL4 activity [5,33], secondary to modification of IL4 gene transcription [34]. In this sense, it has been hypothesized that the T allele may be associated with severity of asthma [23,34,35]. In our study, a trend of association of -33TIL4 allele with persistent asthma was observed.
###end p 49
###begin title 50
###xml 6 12 6 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
576Q>RIL4RA SNP
###end title 50
###begin p 51
###xml 18 24 18 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 140 146 140 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 239 241 239 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 377 385 <span type="species:ncbi:9606">patients</span>
Analysis of 576Q>RIL4RA polymorphism did not reveal any association with asthma phenotype. It has been reported a relationship of the 576Q>RIL4RA SNP with the atopic phenotype, however this relationship is still controversial [19,21-31,36-38]. In a previous study, we did not find any association of this polymorphism with atopy or IgE levels, except in a specific of group of patients with family history of atopy [28].
###end p 51
###begin p 52
###xml 13 15 13 15 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 312 314 312 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 502 504 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
Kruse et al [21] associated the R allele with lower total IgE values, but Hersey et al [19]found an association with high levels of total IgE. We did not detect any association with IgE levels. Genetic association studies are often difficult to interpret due to poor reproducibility in different populations [39,40]. This may well result, among other reasons, from the fact that these studies are focused only on one SNP [18,26,27] and that penetrance of the alleles may be influence by other factors [19].
###end p 52
###begin title 53
Gene-gene interaction analysis
###end title 53
###begin p 54
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 235 241 235 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 85 93 <span type="species:ncbi:9606">patients</span>
###xml 148 156 <span type="species:ncbi:9606">patients</span>
When we analysed both polymorphisms simultaneously, differences between the group of patients with asthma and controls were detected. Particularly, patients who were carriers of both the T allele of -33C>TIL4 and the A allele of 576Q>RIL4RA had an increased risk of asthma.
###end p 54
###begin p 55
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 197 203 197 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 54 62 <span type="species:ncbi:9606">patients</span>
###xml 119 127 <span type="species:ncbi:9606">patients</span>
Significant differences were observed in the group of patients with allergic asthma compared to controls. In addition, patients who carried both the T allele of -33C>TIL4 and the A allele of 576Q>RIL4RA had an increased risk of persistent asthma, in our population.
###end p 55
###begin p 56
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 756 766 756 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4/IL4RA </italic>
It has been previously suggested that both SNPs may modify the susceptibility to atopy or atopic asthma, independently. The importance of analysis of genetic variants has been previously illustrated, because the functional significance of a given polymorphism may only be evident in a specific setting of additional SNPs in the same or different genes [40]. It has also been pointed out that genetic association studies need careful classification of phenotypes, application of quality control in the performance of laboratory procedures and very stringent significant levels to assure reproducibility [20,39]., although it also may indicate true heterogeneity in gene-disease associations. We describe for the first time a specific genetic combination of IL4/IL4RA polymorphisms that shows a trend of association to persistent asthma in a South European population. As long as this study was performed in a small population, further studies in other populations are needed to confirm these results.
###end p 56
###begin title 57
Conclusion
###end title 57
###begin p 58
###xml 45 49 45 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4 </italic>
###xml 203 209 203 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IL4RA </italic>
###xml 125 133 <span type="species:ncbi:9606">Patients</span>
###xml 343 351 <span type="species:ncbi:9606">patients</span>
We show a trend of association between -33C>TIL4 and 576Q>RIL4RA polymorphisms and asthma phenotype in a Spanish population. Patients who carried both the T allele of -33C>TIL4 and the A allele of 576Q>RIL4RA showed an increased risk of allergic asthma. In the population included in our study this combination was observed more frequently in patients with persistent asthma.
###end p 58
###begin title 59
Competing interests
###end title 59
###begin p 60
The author(s) declare that they have no competing interests.
###end p 60
###begin title 61
Authors' contributions
###end title 61
###begin p 62
MIG participated in the design of the study, carried out the molecular genetic studies, performed the statistical analysis and drafted the manuscript.
###end p 62
###begin p 63
IDG participated in the design of the study, coordinated the clinical aspects of the study, helped to perform the statistical aspects and to draft the manuscript.
###end p 63
###begin p 64
EL participated in the clinical aspects of the study.
###end p 64
###begin p 65
EM participated in the clinical aspects of the study.
###end p 65
###begin p 66
FL participated in the design and coordination of the study.
###end p 66
###begin p 67
RGS conceived the study, participated in its design and coordination and helped to draft the manuscript.
###end p 67
###begin p 68
All authors have read and approved the final manuscript.
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
This work was partially supported by a grant of the Fundacion de la Sociedad Espanola de Alergologia e Inmunologia Clinica and a grant from the Junta de Castilla y Leon.
###end p 70
###begin p 71
The authors would like thank Mrs. Nieves Mateos for her technical support.
###end p 71
###begin article-title 72
Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
###end article-title 72
###begin article-title 73
Allelic association of gene markers on chromosomes 5q and 11q with atopy and bronchial hyperresponsiveness
###end article-title 73
###begin article-title 74
###xml 101 109 <span type="species:ncbi:9606">children</span>
Linkage of chromosome 5q and 11q gene markers to asthma-associated quantitative traits in Australian children
###end article-title 74
###begin article-title 75
A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects
###end article-title 75
###begin article-title 76
Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10)
###end article-title 76
###begin article-title 77
###xml 52 57 <span type="species:ncbi:9606">human</span>
A new polymorphism in the 5' flanking region of the human interleukin (IL)-4 gene
###end article-title 77
###begin article-title 78
A complete screening of the IL4 gene: novel polymorphisms and their association with asthma and IgE in childhood
###end article-title 78
###begin article-title 79
Association between a C+33T polymorphism in the IL-4 promoter region and total serum IgE levels
###end article-title 79
###begin article-title 80
The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood
###end article-title 80
###begin article-title 81
Haplotypes of the 5' region of the IL-4 gene and SNPs in the intergene sequence between the IL-4 and IL-13 genes are associated with atopic asthma
###end article-title 81
###begin article-title 82
The IL-4 receptor: signaling mechanisms and biologic functions
###end article-title 82
###begin article-title 83
###xml 15 20 <span type="species:ncbi:9606">human</span>
Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex
###end article-title 83
###begin article-title 84
###xml 66 71 <span type="species:ncbi:9606">human</span>
###xml 100 105 <span type="species:ncbi:10090">mouse</span>
The interleukin-4 receptor gene (IL4R) maps to 16p11.2-16p12.1 in human and to the distal region of mouse chromosome 7
###end article-title 84
###begin article-title 85
A second-generation genomewide screen for asthma-susceptibility alleles in a founder population
###end article-title 85
###begin article-title 86
Linkage and allelic association of atopy and markers flanking the IL4-receptor gene
###end article-title 86
###begin article-title 87
Common polymorphisms in the coding part of the IL4-receptor gene
###end article-title 87
###begin article-title 88
###xml 112 117 <span type="species:ncbi:9606">human</span>
Identification of a novel single-nucleotide polymorphism (Val554Ile) and definition of eight common alleles for human IL4RA exon 11
###end article-title 88
###begin article-title 89
The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor
###end article-title 89
###begin article-title 90
Effects of common atopy-associated amino acid substitutions in the IL-4 receptor alpha chain on IL-4 induced phenotypes
###end article-title 90
###begin article-title 91
The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction
###end article-title 91
###begin article-title 92
Atopy and asthma: genetic variants of IL-4 and IL-13 signalling
###end article-title 92
###begin article-title 93
Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity
###end article-title 93
###begin article-title 94
A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma
###end article-title 94
###begin article-title 95
Asthma and IL-4 receptor alpha gene variants
###end article-title 95
###begin article-title 96
IL-4 receptor alpha chain genetic polymorphism and total IgE levels in the English population: two-locus haplotypes are more informative than individual SNPs
###end article-title 96
###begin article-title 97
Polymorphisms of IL-4, IL-4R alpha, and AICDA genes in adult allergic asthma
###end article-title 97
###begin article-title 98
###xml 87 95 <span type="species:ncbi:9606">patients</span>
[IL4RA gene polymorphism (Q576R) is associated with higher total IgE levels in Spanish patients with family history of atopy]
###end article-title 98
###begin article-title 99
Haplotypes of the interleukin-4 receptor alpha chain gene associate with susceptibility to and severity of atopic asthma
###end article-title 99
###begin article-title 100
###xml 87 95 <span type="species:ncbi:9606">children</span>
Gene-gene interaction between interleukin-4 and interleukin-4 receptor alpha in Korean children with asthma
###end article-title 100
###begin article-title 101
No linkage or association of five polymorphisms in the interleukin-4 receptor alpha gene with atopic asthma in Italian families
###end article-title 101
###begin article-title 102
SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci
###end article-title 102
###begin article-title 103
Promoter polymorphism in the candidate genes, IL-4, IL-9, TGF-beta1, for atopy and asthma
###end article-title 103
###begin article-title 104
###xml 69 72 <span type="species:ncbi:12672?0.125">FEV</span>
Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma
###end article-title 104
###begin article-title 105
Polymorphisms in the interleukin-4 and interleukin-4 receptor alpha chain genes confer susceptibility to asthma and atopy in a Caucasian population
###end article-title 105
###begin article-title 106
Lack of association of atopy/asthma and the interleukin-4 receptor alpha gene in Japanese
###end article-title 106
###begin article-title 107
###xml 83 91 <span type="species:ncbi:9606">children</span>
Candidate genes and a genome-wide search in Italian families with atopic asthmatic children
###end article-title 107
###begin article-title 108
No linkage or association of the IL-4Ralpha gene Q576R mutation with atopic asthma in Italian families
###end article-title 108
###begin article-title 109
Problems of reporting genetic associations with complex outcomes
###end article-title 109
###begin article-title 110
V75R576 IL-4 receptor alpha is associated with allergic asthma and enhanced IL-4 receptor function
###end article-title 110

